FOXO TECHNOLOGIES INC. Deferred Tax Liabilities, Net
FOXO TECHNOLOGIES INC. (FOXO) had Deferred Tax Liabilities, Net of $2.93 million as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net
us-gaap:DeferredTaxLiabilities · last filed 2026-04-15
- 2025-12-31: Deferred Tax Liabilities, Net $2.93M.
- 2024-12-31: Deferred Tax Liabilities, Net $1.59M.
- 2023-12-31: Deferred Tax Liabilities, Net $10.14K; Deferred Tax Liabilities, Net as first filed $10.00K.
- 2022-12-31: Deferred Tax Liabilities, Net $450.00K.
| Period end | Deferred Tax Liabilities, Net | Deferred Tax Liabilities, Net as first filed |
|---|---|---|
| 2025-12-31 | $2.93M 10-K · filed 2026-04-15 | |
| 2024-12-31 | $1.59M 10-K · filed 2026-04-15 | |
| 2023-12-31 | $10.14K 10-K · filed 2025-04-15 | $10.00K 10-K · filed 2024-06-06 |
| 2022-12-31 | $450.00K 10-K · filed 2024-06-06 | |
| 2021-12-31 | $51.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |